FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Alitretinoin (Panretin) Gel
Status: Currently in Shortage
»Date first posted: 01/17/2017
»Therapeutic Categories: Oncology

Eisai Medical Affairs (Reverified 03/13/2017)

Company Contact Information:
888-274-2378

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Panretin gel 60 Gram Tube (NDC 62856-601-22) Available In order to alleviate the shortage of Panretin gel in the US, the FDA is allowing the sale of Panretin gel tubes approved for use in the European market (EU-approved Panretin gel). Please see Dear Healthcare Provider Letter.

Dear Healthcare Provider Letter

Manufacturing Issue

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English